Linezolid: in infants and children with severe Gram-positive infections.
about
Benefit-risk assessment of linezolid for serious gram-positive bacterial infections.Staphylococcal skin infections in children: rational drug therapy recommendations.Linezolid: a new antibiotic for newborns and children?Prevalence and antimicrobial resistance pattern of methicillin resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens in Ardabil, Iran.Economic evaluation of linezolid versus teicoplanin for the treatment of infections caused by gram-positive microorganisms in Spain.
P2860
Linezolid: in infants and children with severe Gram-positive infections.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Linezolid: in infants and children with severe Gram-positive infections.
@ast
Linezolid: in infants and children with severe Gram-positive infections.
@en
type
label
Linezolid: in infants and children with severe Gram-positive infections.
@ast
Linezolid: in infants and children with severe Gram-positive infections.
@en
prefLabel
Linezolid: in infants and children with severe Gram-positive infections.
@ast
Linezolid: in infants and children with severe Gram-positive infections.
@en
P1433
P1476
Linezolid: in infants and children with severe Gram-positive infections.
@en
P2093
Karen L Goa
P304
419-29; discussion 430-1
P356
10.2165/00128072-200305060-00009
P577
2003-01-01T00:00:00Z
P6179
1031788870